NL-OMON49525撤回不适用
iraglutide for low-responders after bariatric surgery - LIBAR
ederlandse Obesitas Kliniek0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Patient is *18 and <75 years old
- •* BMI before surgery was * 35.0 kg/m2
- •* Patient is treated with group consultation at the NOK
- •* Patient has undergone a primary Roux-en-Y gastric bypass (RYGB) or sleeve
- •gastrectomy (SG)
- •* Patient is in the lowest %TWL quartile, 3 months after surgery and will be
- •enrolled in the plus module.
排除标准
- •* Type 1 or type 2 diabetes
- •* Decreased renal function (creatinine clearance < 30 ml/min)
- •* Liver failure (all)
- •* Congestive heart failure or angina pectoris NYHA class III and IV
- •* Malignancy in history
- •* Pancreatitis (in history)
- •* Pregnancy / breast-feeding
- •* Inflammatory Bowel Disease
- •* Thyroid malignancy in history
- •* Use of warfarin or other coumarin derivates
研究者
相似试验
进行中（未招募）
1 期
iraglutide for patients who have undergone bariatric surgery and do not achieve sufficient weight loss.Morbid obesityEUCTR2020-000548-71-NLederlandse Obesitas Kliniek100
撤回
不适用
Liraglutide for Low-responders After Bariatric SurgeryObesity, MorbidObesityNCT04643301Zuyderland Medisch Centrum
进行中（未招募）
1 期
iraglutide and the management of overweight and obesity in people with schizophreniaSchizophrenia, schizoaffective disorder or first episode psychosisEUCTR2017-004064-35-GBSouthern Health NHS Foundation Trust60
已完成
3 期
iraglutide and the management of overweight and obesity in people with schizophreniaMental and Behavioural DisordersSchizophrenia, schizotypal and delusional disordersSchizophreniaISRCTN61129760Southern Health NHS Foundation Trust47
已完成
2 期
Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve GastrectomyStatus Post Sleeve GastrectomyObesityNCT04883346Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)34